Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Rous sarcoma virus was shown to induce in chicken embryo fibroblasts (CEF) a 4.1-kilobase mRNA (designated CEF-147) encoding a 603-amino acid protein. Analysis of the protein sequence showed that it shared 59% amino acid identity with sheep prostaglandin G/H synthase, the enzyme that catalyzes the rate-limiting steps in the production of prostaglandins. Significant differences, at both the protein and mRNA levels, existed between the src oncogene product-inducible prostaglandin synthase and the protein isolated and cloned from sheep seminal vesicle, suggesting that the src-inducible prostaglandin synthase may be a new form of the enzyme. A distinguishing feature of src-inducible prostaglandin synthase mRNA is its low abundance in nonproliferating chicken embryo fibroblasts and its relatively high abundance in src-transformed cells. Additionally, the majority of the src-inducible prostaglandin synthase RNA present in nonproliferating cells was found to be nonfunctional because of the presence of an unspliced intron that separated the signal peptide from the remainder of the protein. Upon mitogenic stimulation, this intron was removed, resulting in the induction of fully-spliced CEF-147 mRNA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Church, G. M., & Gilbert, W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.1991 · Cited by 8,116
Aviv, H., & Leder, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1408 · Cited by 6,751
Shaw, G., & Kamen, R. (1986) · Cell · doi:10.1016/0092-8674(86)90341-7 · Cited by 4,012
The scanning model for translation: an update.
Kozak, M. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.2.229 · Cited by 3,486
Purification of Mouse Immunoglobulin Heavy‐Chain Messenger RNAs from Total Myeloma Tumor RNA
AUFFRAY, C., & ROUGEON, F. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06030.x · Cited by 2,627
Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown-Shimer, S., & Cerami, A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1670 · Cited by 1,516
Cited by
Items 101–174 of 174
Zhang, J., Ding, E. L., & Song, Y. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60015 · Cited by 332
COX-2 Inhibitors and Cardiovascular Risk
Funk, C. D., & FitzGerald, G. A. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318157f72d · Cited by 330
EHRICH, E., DALLOB, A., DELEPELEIRE, I., VANHECKEN, A., RIENDEAU, D., YUAN, W., PORRAS, A., WITTREICH, J., SEIBOLD, J., & DESCHEPPER, P. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70113-x · Cited by 322
Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
Mitchell, J. A., & Warner, T. D. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702897 · Cited by 321
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
ROSSAT, J., MAILLARD, M., NUSSBERGER, J., BRUNNER, H., & BURNIER, M. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70056-1 · Cited by 318
Cell signalling by reactive lipid species: new concepts and molecular mechanisms
Higdon, A., Diers, A. R., Oh, J. Y., Landar, A., & Darley-Usmar, V. M. (2012) · Biochemical Journal · doi:10.1042/bj20111752 · Cited by 317
Resveratrol addiction: To die or not to die
Shakibaei, M., Harikumar, K. B., & Aggarwal, B. B. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800148 · Cited by 316
COX-2: A Target for Colon Cancer Prevention
Marnett, L. J., & DuBois, R. N. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082301.164620 · Cited by 313
Gomez, R., Romero, R., Edwin, S. S., & David, C. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70347-0 · Cited by 312
Selective inhibition of cyclooxygenase-2 by C-phycocyanin, a biliprotein from Spirulina platensis
Reddy, C. M., Bhat, V. B., Kiranmai, G., Reddy, M. N., Reddanna, P., & Madyastha, K. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3725 · Cited by 310
Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor
GOLDSTEIN, J., SILVERSTEIN, F., AGRAWAL, N., HUBBARD, R., KAISER, J., MAURATH, C., VERBURG, K., & GEIS, G. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00986-2 · Cited by 308
Mitchell, J. A., Belvisi, M. G., Akarasereenont, P., Robbins, R. A., Kwon, O. ‐., Croxtall, J. J., Barnes, P. J., & Vane, J. R. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17093.x · Cited by 307
Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs
Xie, W., Robertson, D. L., & Simmons, D. L. (1992) · Drug Development Research · doi:10.1002/ddr.430250402 · Cited by 306
Self-citationHermsmeier, D., Schittko, U., & Baldwin, I. T. (2001) · Plant Physiology · doi:10.1104/pp.125.2.683 · Cited by 306
Sirois, J., & Richards, J. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42706-8 · Cited by 306
Cyclooxygenase-3 (COX-3): Filling in the gaps toward a COX continuum?
Warner, T. D., & Mitchell, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222543099 · Cited by 302
Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis
Ota, H., Igarashi, S., Sasaki, M., & Tanaka, T. (2001) · Human Reproduction · doi:10.1093/humrep/16.3.561 · Cited by 302
Hempel, S. L., Monick, M. M., & Hunninghake, G. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116971 · Cited by 301
Fatty Acid Substrate Specificities of Human Prostaglandin-endoperoxide H Synthase-1 and −2
Laneuville, O., Breuer, D. K., Xu, N., Huang, Z. H., Gage, D. A., Watson, J. T., Lagarde, M., DeWitt, D. L., & Smith, W. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19330 · Cited by 301
Physiological regulation of cyclooxygenase-2 in the kidney
Harris, R. C., & Breyer, M. D. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.1.f1 · Cited by 301
COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease
Willoughby, D. A., Moore, A. R., & Colville-Nash, P. R. (2000) · The Lancet · doi:10.1016/s0140-6736(99)12031-2 · Cited by 298
Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
Crofford, L. J., Lipsky, P. E., Brooks, P., Abramson, S. B., Simon, L. S., & Van De Putte, L. B. A. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<4::aid-anr2>3.0.co;2-v · Cited by 296
Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia
Fosslien, E. (2000) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360091174286 · Cited by 296
Paulson, S. K., Vaughn, M. B., Jessen, S. M., Lawal, Y., Gresk, C. J., Yan, B., Maziasz, T. J., Cook, C. S., & Karim, A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29580-x · Cited by 289
Xie, W., & Herschman, H. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27622 · Cited by 288
Self-citationMurias, M., Handler, N., Erker, T., Pleban, K., Ecker, G., Saiko, P., Szekeres, T., & Jäger, W. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.08.008 · Cited by 288
Habib, A., Créminon, C., Frobert, Y., Grassi, J., Pradelles, P., & Maclouf, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49483-0 · Cited by 288
Schmassmann, A., Peskar, B. M., Stettler, C., Netzer, P., Stroff, T., Flogerzi, B., & Halter, F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701672 · Cited by 287
Celecoxib: A Review of its Use in Osteoarthritis, Rheumatoid Arthritis and Acute Pain
Clemett, D., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200059040-00017 · Cited by 287
Kinetic basis for selective inhibition of cyclo-oxygenases
Gierse, J. K., Koboldt, C. M., Walker, M. C., Seibert, K., & Isakson, P. C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3390607 · Cited by 287
Paramashivappa, R., Phani Kumar, P., Subba Rao, P. V., & Srinivasa Rao, A. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01006-5 · Cited by 287
HALTER, F., TARNAWSKI, A. S., SCHMASSMANN, A., & PESKAR, B. M. (2001) · Gut · doi:10.1136/gut.49.3.443 · Cited by 285
Klein-Nulend, J., Burger, E. H., Semeins, C. M., Raisz, L. G., & Pilbeam, C. C. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.1.45 · Cited by 285
Cyclooxygenases and the Central Nervous System
Kaufmann, W. E., Andreasson, K. I., Isakson, P. C., & Worley, P. F. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00128-7 · Cited by 285
Elmquist, J. K., Breder, C. D., Sherin, J. E., Scammell, T. E., Hickey, W. F., Dewitt, D., & Saper, C. B. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970505)381:2<119::aid-cne1>3.0.co;2-6 · Cited by 283
Mitchell, J. A., & Warner, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1929 · Cited by 279
NIH Consensus Statement on Total Knee Replacement December 8-10, 2003*
(2004) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200406000-00030 · Cited by 269
Mechanism of Free Radical Oxygenation of Polyunsaturated Fatty Acids by Cyclooxygenases
Rouzer, C. A., & Marnett, L. J. (2003) · Chemical Reviews · doi:10.1021/cr000068x · Cited by 266
Renal Effects of COX-2-Selective Inhibitors
Brater, D. C., Harris, C., Redfern, J. S., & Gertz, B. J. (2001) · American Journal of Nephrology · doi:10.1159/000046212 · Cited by 265
Day, R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.12.1781 · Cited by 264
Prostanoid production via COX-2 as a causative mechanism of rodent postoperative ileus
Schwarz, N. T., Kalff, J. C., Türler, A., Engel, B. M., Watkins, S. C., Billiar, T. R., & Bauer, A. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.29605 · Cited by 257
Sirois, J., Simmons, D. L., & Richards, J. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49951-1 · Cited by 255
Self-citationMcAdam, B. F., Mardini, I. A., Habib, A., Burke, A., Lawson, J. A., Kapoor, S., & FitzGerald, G. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9523 · Cited by 253
Cao, C., Matsumura, K., Yamagata, K., & Watanabe, Y. (1995) · Brain Research · doi:10.1016/0006-8993(95)00839-i · Cited by 252
Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties
Kis, B., Snipes, J. A., & Busija, D. W. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085431 · Cited by 250
“A COX-2 splice variant with retention of the intron between exons 1 and 2 was described in chicken embryo fibroblasts (Xie et al., 1991), and a COX-2 splice variant with an unspliced intron between exons 7 and 8 was reported in human myometrium (Huang et al., 2003).”
BackgroundExpression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide
Hwang, D., Jang, B. C., Yu, G., & Boudreau, M. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00154-8 · Cited by 248
Warner, T. D., Nylander, S., & Whatling, C. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03943.x · Cited by 245
Sohail, R., Mathew, M., Patel, K. K., Reddy, S. A., Haider, Z., Naria, M., Habib, A., Abdin, Z. U., Razzaq Chaudhry, W., & Akbar, A. (2023) · Cureus · doi:10.7759/cureus.37080 · Cited by 239
Claria, J. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454054 · Cited by 238
“But still a number of questions remained unanswered; such as why the toxicity of NSAIDs differs in the gastrointestinal tract when used at similar antiinflammatory doses? The answer was provided in the early 1990 ́s when it was established that there are at least two COX isozymes present in human cells: COX-1, which i…”
BackgroundSirois, J., & Richards, J. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80630-9 · Cited by 234
Langenbach, R., Loftin, C., Lee, C., & Tiano, H. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00158-6 · Cited by 230
Breder, C. D., Hazuka, C., Ghayur, T., Klug, C., Huginin, M., Yasuda, K., Teng, M., & Saper, C. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11393 · Cited by 226
Romano, M., & Clària, J. (2003) · The FASEB Journal · doi:10.1096/fj.03-0053rev · Cited by 222
“COX-1 and COX-2 are the products of two distinct genes, which in humans are localized on chromosomes 9 and 1, respectively (4, 5).”
BackgroundInfluentialMurakami, M., Matsumoto, R., Austen, K. F., & Arm, J. P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31786-6 · Cited by 217
Cyclooxygenase-2 and its role in ovulation: a 2004 account
Sirois, J., Sayasith, K., Brown, K. A., Stock, A. E., Bouchard, N., & Doré, M. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh032 · Cited by 212
“COX-2 cDNA's were first isolated as immediate –early genes expressed in virally transformed chicken embryo fibroblasts (Xie et al., 1991) and in mitogenstimulated Swiss 3T3 cells (Kujubu et al., 1991), but the presence of a COX isoform distinct from COX-1 had been suspected prior to its cloning…”
BackgroundInfluentialSirois, J. (1994) · Endocrinology · doi:10.1210/en.135.3.841 · Cited by 208
Role of cyclooxygenase-2 in colorectal cancer
Sinicrope, F. A., & Gill, S. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025863029529 · Cited by 197
“COX-2 expression was induced in cells transformed with the v-src oncogene [20] or treated with phorbol esters [21].”
MethodJouzeau, J.-Y., Terlain, B., Abid, A., Nédélec, E., & Netter, P. (1997) · Drugs · doi:10.2165/00003495-199753040-00003 · Cited by 192
Paracetamol – An old drug with new mechanisms of action
Przybyła, G. W., Szychowski, K. A., & Gmiński, J. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13392 · Cited by 190
5 Selective Inhibitors of Cyclooxygenase-2 (COT-2)
Talley, J. J. (1999) · Progress in Medicinal Chemistry · doi:10.1016/s0079-6468(08)70048-1 · Cited by 178
The Coxib NSAIDs: Potential Clinical and Pharmacologic Importance in Veterinary Medicine
Bergh, M. S., & Budsberg, S. C. (2005) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2005.tb02741.x · Cited by 178
Gastrointestinal effects of nonsteroidal anti‐inflammatory drugs
Whittle, B. J. R. (2003) · Fundamental & Clinical Pharmacology · doi:10.1046/j.1472-8206.2003.00135.x · Cited by 172
LANGENBACH, R., LOFTIN, C. D., LEE, C., & TIANO, H. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08723.x · Cited by 170
Pall, M. (2001) · Human Reproduction · doi:10.1093/humrep/16.7.1323 · Cited by 169
Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy
Wallace, J. L. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i12.1861 · Cited by 168
Neuronal death and survival in two models of hypoxic-ischemic brain damage
Walton, M., Connor, B., Lawlor, P., Young, D., Sirimanne, E., Gluckman, P., Cole, G., & Dragunow, M. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00053-8 · Cited by 165
Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain
Madrigal, J. L. M., Moro, M. A., Lizasoain, I., Lorenzo, P., Fernández, A. P., Rodrigo, J., Boscá, L., & Leza, J. C. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300187 · Cited by 155
“COX exists as two distinct isoforms (Fu et al, 1990; Xie et al, 1991): whereas COX-1 is constitutively expressed as a housekeeping enzyme in nearly all tissues, mediating physiological responses, COX-2 is rapidly and transiently induced in cells that are involved in inflammation and is primarily…”
BackgroundCyclooxygenase Inhibition as a Strategy to Ameliorate Brain Injury
Hurley, S. D., Olschowka, J. A., & O'Banion, M. K. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753460196 · Cited by 110
(1992) · PubMed · Cited by 85
Ayoub, S. S., Colville-Nash, P. R., Willoughby, D. A., & Botting, R. M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.061 · Cited by 79
Ayoub, S. S., Yazid, S., & Flower, R. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.166 · Cited by 48
“COX-1 is constitutively expressed and is generally responsible for the production of prostanoids involved in homoeostatic regulation of body functions (Crofford, 1997), whereas COX-2 is an inducible isoform (Xie et al., 1991) in most tissues (although substantial pools of the enzyme exist constitutively in some organs…”
BackgroundIntestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts
Petruzzelli, M., Vacca, M., Moschetta, A., Cinzia Sasso, R., Palasciano, G., van Erpecum, K. J., & Portincasa, P. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.01.015 · Cited by 46
Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?
Esh, C. J., Chrismas, B. C. R., Mauger, A. R., & Taylor, L. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.835 · Cited by 38
Non-steroidal Anti-inflammatory Drugs and Pain
Appleton, I. (1997) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-60777-6_3 · Cited by 11
Metadata
- Authors
- Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., & Simmons, D. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1991-04
- Volume
- 88
- Issue
- 7
- Pages
- 2692-2696
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2113745276
- Cited by
- 1,707
- References
- 25
- FWCI
- 16.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.